Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10813968rdf:typepubmed:Citationlld:pubmed
pubmed-article:10813968lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:10813968lifeskim:mentionsumls-concept:C1155874lld:lifeskim
pubmed-article:10813968lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10813968lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:10813968lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10813968lifeskim:mentionsumls-concept:C0762067lld:lifeskim
pubmed-article:10813968pubmed:issue2lld:pubmed
pubmed-article:10813968pubmed:dateCreated2000-10-10lld:pubmed
pubmed-article:10813968pubmed:abstractTextA concise, improved synthesis of isogranulatimide (6), a naturally occurring substance with G2 checkpoint inhibition activity, is described. Also reported are the syntheses of didemnimide C (18), isodidemnimide A (24), neodidemnimide A (36), 17-methylgranulatimide (9), and isogranulatimides A (10), B (11), and C (12). Compounds 9-12, congeners of isogranulatimide (6), are now available for biological evaluation.lld:pubmed
pubmed-article:10813968pubmed:languageenglld:pubmed
pubmed-article:10813968pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10813968pubmed:citationSubsetIMlld:pubmed
pubmed-article:10813968pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10813968pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10813968pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10813968pubmed:statusMEDLINElld:pubmed
pubmed-article:10813968pubmed:monthJanlld:pubmed
pubmed-article:10813968pubmed:issn0022-3263lld:pubmed
pubmed-article:10813968pubmed:authorpubmed-author:BrittonRRlld:pubmed
pubmed-article:10813968pubmed:authorpubmed-author:AndersenR JRJlld:pubmed
pubmed-article:10813968pubmed:authorpubmed-author:PiersEElld:pubmed
pubmed-article:10813968pubmed:issnTypePrintlld:pubmed
pubmed-article:10813968pubmed:day28lld:pubmed
pubmed-article:10813968pubmed:volume65lld:pubmed
pubmed-article:10813968pubmed:ownerNLMlld:pubmed
pubmed-article:10813968pubmed:authorsCompleteYlld:pubmed
pubmed-article:10813968pubmed:pagination530-5lld:pubmed
pubmed-article:10813968pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10813968pubmed:meshHeadingpubmed-meshheading:10813968...lld:pubmed
pubmed-article:10813968pubmed:meshHeadingpubmed-meshheading:10813968...lld:pubmed
pubmed-article:10813968pubmed:meshHeadingpubmed-meshheading:10813968...lld:pubmed
pubmed-article:10813968pubmed:meshHeadingpubmed-meshheading:10813968...lld:pubmed
pubmed-article:10813968pubmed:meshHeadingpubmed-meshheading:10813968...lld:pubmed
pubmed-article:10813968pubmed:year2000lld:pubmed
pubmed-article:10813968pubmed:articleTitleImproved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses Of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C.lld:pubmed
pubmed-article:10813968pubmed:affiliationDepartments of Chemistry and Earth and Ocean Sciences, 2036 Main Mall, University of British Columbia, Vancouver, BC, Canada V6T 1Z1.lld:pubmed
pubmed-article:10813968pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10813968pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10813968lld:pubmed